PLC Medical SystemsWelcomes New VP PLC Medical Systems Inc. has named Susan Papalia, R.N., B.S.N.

PLC Medical SystemsWelcomes New VP

PLC Medical Systems Inc. has named Susan Papalia, R.N., B.S.N., as its new vice president of clinical affairs. Papalia will oversee the U.S. clinical study of RenalGuard, a product designed to help prevent the onset of Contrast-Induced Nephropathy. The CE-marked product currently is being marketed in Europe and selected countries worldwide.

“Susan brings to PLC more than 20 years of experience in clinical research and regulatory approvals related to the launch of new medical devices in the United States and international markets,” said Mark R. Tauscher, president and CEO.

Papalia previously served as vice president of clinical affairs at Correx Inc., where she helped launch the Correx Aortic Valve Bypass kit in the European Union and Canada. She also has held several senior clinical affairs positions at Boston Scientific Corp. and Mitralign Inc., a Tewksbury, Mass., firm that has developed a catheter-based mitral valve repair system.

PLC Systems is headquartered in Franklin, Mass.